BPA Call W81K0020A0003-HT009023FG1030065
Award Date
10/6/22
Potential Completion Date
9/30/23
Potential Value
$21K
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cayce, SC 29172, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Health Agency (DHA) to Nephron Sterile Compounding Center LLC, a self-certified small disadvantaged business and woman-owned limited liability company. The contract, valued at $37,586.64, is for the provision of various pharmaceutical products and supplies, including specific medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for Injection, and Buffered Lidocaine Buffer in...
This is a federal contract award from the Defense Health Agency (DHA) to Nephron Sterile Compounding Center LLC, a woman-owned small disadvantaged business based in West Columbia, South Carolina. The $112,760.04 firm fixed price Blanket Purchase Agreement (BPA) call contract is for the delivery of Pharmaceuticals - Anesthesia Pre-Filled Syringes to support DHA's healthcare programs. The contract has an ultimate completion date of September 30, 2025 and was awarded on January 30, 2025 without any...
This is a $57,600 firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services (HHS), to Nephron Sterile Compounding Center LLC, a small disadvantaged business. The contract is for a Blanket Purchase Agreement (BPA) to provide pharmaceutical products and supplies, including medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for...
This firm fixed price contract for $12,000 was awarded by the Defense Health Agency to Nephron Sterile Compounding Center LLC on October 6, 2022. The contract is associated with a Blanket Purchase Agreement to provide buffered lidocaine buffer in sodium bicarbonate, as well as other pharmaceutical products and supplies, through September 30, 2023. Nephron 503B Outsourcing Facility will deliver the specified medications and general pharmacy supplies. No set-aside designation was used for this...
This contract award is for the delivery of various shortage pharmaceuticals to the Defense Health Agency, an agency within the Department of Defense. The prime contractor, The Compounding Center Inc., is a minority-owned, small disadvantaged business that provides specialized pharmaceutical compounds and medical supplies to government agencies. The contract is a blanket purchase agreement with a ceiling value of $300,000.00, allowing for the expedited acquisition of customized medications and...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded on June 9, 2021 by the Defense Health Agency to provide pharmaceutical supplies in support of agency programs. With a potential value of $25,000, the contract has a completion date of June 6, 2022 and calls off of an existing BPA for these products and services. The Compounding Center Inc. of Bethesda, Maryland will deliver the requested pharmaceutical supplies to locations within that city. No set-aside designation...
The Defense Health Agency awarded a firm fixed price blanket purchase agreement call contract valued at sixty-five thousand dollars to The Compounding Center Inc. of Bethesda, Maryland. The contract is for the delivery of ATROPHINE DEXTROSE HEPARIN HYDRALAZINE with no set-aside designation applied. The place of performance is Bethesda, Maryland and the completion date is March 16, 2022, which is also the award date. No major subcontractors were identified. The Defense Health Agency supports...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4566842965 ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,980.18 and a period of performance through January 7, 2025. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rocuronium 50 mg/5 ml vials. The $1,374.24 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This is a $1,105.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567367457 ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical commodity, to support federal healthcare programs. The award is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...